What's breaking now, across thousands of outlets.
Key PointsThe Invesco Nasdaq Biotechnology ETF carries a lower expense ratio and delivered higher total returns over the trailing 12 months than the iShares U.S. Healthcare ETF.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
When the U.S. Food and Drug Administration (FDA) was deciding whether to approve the drug Tavneos several years ago to treat a set of rare autoimmune diseases, but agency experts argued that would be…
Key PointsCostco’s membership model, scale, and focus on value can help it hold up when consumers get cautious.
China’s oil imports are likely to remain subdued in the coming months if crude prices stay elevated, according to Goldman Sachs Group Inc., which could keep a lid on further gains.
ISLAMABAD: A Senate panel on Tuesday questioned the legal basis of the Federal Investigation Agency (FIA) launching independent tax inquiries — a domain of the Federal Board of Revenue (FBR) — and…
Charlie Hunnam talks about going from playing serial killer Ed Gein to Andrew Borden, Lizzie Borden’s father and victim, in Netflix’s ‘Monster.’
SEOUL, Sept. 23 (Yonhap) -- South Korean stocks trimmed their earlier gains late...
